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Protein kinase C alphaCell-penetrating peptides (CPPs) are short peptides capable of translocating across the plasma membrane of
live cells and transporting conjugated compounds intracellularly. Fifteen years after discovering the ﬁrst
model cationic CPPs, penetratin and TAT, CPP internalization is still challenging many questions. Particularly
it has been unknown whether CPPs enter the cells with or without mediation of a speciﬁc surface receptor.
Here we report that syndecan-4, the universally expressed isoform of the syndecan family of transmembrane
proteoglycans, binds and mediates transport of the three most frequently utilized cationic CPPs (penetratin,
octaarginine and TAT) into the cells. Quantitative uptake studies and mutational analyses demonstrate that
attachment of the cationic CPPs is mediated by speciﬁc interactions between the heparan sulfate chains of
syndecan-4 and the CPPs. Protein kinase C alpha is also heavily involved in the uptake mechanism. The
collected data give the ﬁrst direct evidence on the receptor-mediated uptake of cationic CPPs and may
replace the long-thought, but already contradicted membrane penetration hypothesis. Thus our study might
give an answer for a decade long debate and foster the development of rationalized, syndecan-4 targeted
novel delivery technologies.logical Research Center of the
ári krt. 62, Hungary. Tel.: +36
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Cell-penetrating peptides (CPPs) are short peptides with a maxi-
mum length of 30 amino acids capable of translocating across the
plasmamembrane of live cells and transporting conjugated compounds
intracellularly. In recent biomedical research CPP-mediated import of
membrane impermeable biomolecules (such as polypeptides and
oligonucleotides) has become a popular approach to modulate cellular
functions [1–6]. Throughout the years CPPs have proven their superb
vector abilities by delivering a wide range of bioactive agents including
peptides, proteins, oligonucleotides and drugs intracellularly both in
vitro and invivo [6–10]. Fifteen years after theﬁrst publisheddata on the
earliest CPPs, the exact mechanism of CPP internalization is still
challenging lots of questions and it is not yet known whether cellular
entry of CPPs happenswith or without themediation of speciﬁc cellular
receptors [11]. Despite the hidden details of CPP translocation, severallines of evidence suggest themajor role ofheparansulfateproteoglycans
(HSPGs) in interaction with CPPs on the cell surface [12–16].
Particularly, it has been shown that soluble polyanions such as heparin
or heparan sulfate (HS) and removal of cell surface polyanionic HS
chains of proteoglycans (PGs) using heparitinase abrogates CPP
translocation [15,17–19]. However, the identity of the certain HSPG
and its contribution to cellular internalization of CPPs has not yet been
identiﬁed.
Cell surface HSPGs, substantially more abundant than most
receptors, modulate encounters of extracellular protein ligands with
their receptors by forming HS-protein complexes [20–23]. Two types
of HSPGs can be present on the cell surface: the glycosyl-phosphatidyl-
inositol anchored glypicans are expressed predominantly in the
central nervous system and the integral transmembrane protein
syndecans (SDCs) that are more ubiquitous [24]. The four-member
family of SDCs belongs to the type I transmembrane proteins that bear
HS chains on their extracellular domains (Fig. 1). They share a similar
structure: a conserved short, one span transmembrane domain (TM)
and the following approximately 30 amino acid length cytoplasmic
domain (CD). The N-terminal, divergent extracellular domains
(ectodomain) contain three glycosaminoglycan (GAG) attachment
sites for HS near the N-terminus and may bear chondroitin sulfate at
Fig. 1. Schematic representation of the SDC family.
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also compromise cell-binding domains (CBDs) mediating cell–cell
attachment [27]. The HS chains of SDCs consist of repeated uronic acid
and N-acetylglucosamine disaccharides (40–100) forming long un-
branched anionic strings, which contain sections alternately exten-
sively or sparsely sulfated. Interaction between SDCs and their ligands
is mediated by speciﬁc contacts between sulfated regions of the HS
chains and the basic residues on the surface of the ligand [28]. To date,
there are four members of the SDC family: SDC1, expressed on
epithelial and plasma cells; SDC2, on endothelial cells and ﬁbroblasts;
SDC3, predominantly found in the nervous system; and SDC4,
universally expressed [25]. SDC4 is the main, Ca2+-independent
activator of the protein kinase C alpha (PKCα) [29–32]. It participates
in focal adhesions, and via its cytoplasmic domain attaches to the
cytoskeleton [33]. SDC4 is targeted to lipid rafts, discrete regions of the
plasma membrane enriched in cholesterol and sphingolipids. Ligand
or antibody mediated clustering leads to redistribution of SDC4 to
membrane rafts and stimulation of a lipid raft-dependent, but clathrin-
independent endocytosis of the core protein [34]. Endocytosis of SDC4
can be induced by several agents (e.g. FGF2) and blocked by inhibitors
of macropinocytosis like amiloride. However disruption of lipid rafts
and inhibition of macropinocytosis have been also shown to abrogate
CPPuptake, supporting further evidence on the possible role of SDC4 in
CPP translocation [35–37]. Still, apart from a previous report on SDC2
enhancing the uptake of arginine-rich peptides (TAT and polyargi-
nine), no othermembers of the SDC familywas directly investigated in
the cellular entry of CPPs [13]. On the other hand, SDC2 ectodomain
has been shown to inhibit gene transfer mediated by cationic polymer
polyethyleneimine [38]. Therefore it was high time to address the
contribution of the various SDC isoforms to CPP uptake.
Penetratin, a sixteen amino acid long model cationic CPP derived
from the third helix of the Antennapedia homeodomain, is one of the
ﬁrst and up-till-now most frequently utilized and studied CPP [39].
Early studies with penetratin led to the widely accepted and long
lasting cell-penetration hypothesis, rejecting the role of endocytosis
and cellular receptors in CPP uptake [40,41]. However more recent
results on the endocytic uptake of CPPs shattered the formerly
proposed models of cellular entry, raising the importance to revise
earlier views, such as the neglected role of cell surface receptors in
CPP translocation [11,17,42,43].
To analyze the contribution of SDCs to CPP entry, we applied the
three representative model cationic CPPs: penetratin, octaarginine
(R8) and TAT on transfectants expressing the most common SDC
isoforms (SDC1, SDC2 and SDC4). Using a methodology that allows
quantitative analysis of cellular internalization, we identiﬁed the SDC
isoform that facilitates the cellular uptake of CPPs and carries them
through the plasma membrane into the cytosol. Biochemical andmutational analysis revealed the inﬂuence of various parts of the SDC
extracellular domain on cellular entry of the CPPs.
The collected data give the ﬁrst direct evidence on the receptor-
mediated uptake of cationic CPPs and may replace the long-thought,
but already contradicted membrane penetration hypothesis. Thus our
study might give an answer for a decade long debate and represents
cationic CPPs as ligands rather than self-penetrating molecules.
2. Materials and methods
2.1. Peptide synthesis and labeling
Penetratin (RQIKIWFQNRRMKWKK), R8 (RRRRRRRR) and TAT
(YGRKKRRQRRR) were synthesized on a Rink Amide-AM resin (GL
Biochem Ltd) using Nα-Fmoc protected L-amino acids. Peptide chain
elongation was carried out using DCC/HOBt (1:1) activation and
threefold molar excess of amino acids in a DCM/DMF (1:1) mixture.
The N-terminal Fmoc-group was removed by treating the peptide-
resin with 20% piperidine/DMF (5+20 min). Flourescently labeled
CPPs were synthesized by extending the N-terminus of the peptides
with a Gly-Gly-Gly linker followed by the coupling of ﬂuorescein
isothiocyanate (FITC; Sigma Aldrich) with the method of Fulop et al.
[44]. Peptides were cleaved from the resin by incubating it in a
mixture of TFA/water/thioanisole/phenol/DTT (87.5:2.5:5:2.5:2.5%)
for 3 h prior to ether precipitation. The crude products were dissolved
in an acetic acid/water mixture and lyophilized. Peptides were then
puriﬁed on a preparative C18 HPLC column, analyzed by using an
analytical C18 HPLC column and ESI mass spectrometry. The pure
fractions were pooled and lyophilized. The CPPs were also labeled
with Alexa Flour® 555 (Alexa555) dye. First a Cys-Gly-Gly-Gly-CPP
was synthesized and puriﬁed, then Alexa Flour® 555 C2-maleimide
(Invitrogen) was reacted with ﬁve time molar excess of the peptide in
0.2 M NH4OAc (pH=7.1) for 3 h. The reaction mixture was puriﬁed
on a semipreparative C18 HPLC column.
2.1.1. Vector constructs
Full-length SDC1, SDC2, SDC4 and deletion mutants were
ampliﬁed and subcloned in the mammalian expression plasmid
obtained from Clontech (pcDNA3, pEGFP). The SDC-chimeras were
constructed by inserting green ﬂuorescent proteins (GFP) into the
juxtamembrane region of the extracellular segment. The signals were
kept in all cases to orient the proteins into the membrane.
2.2. Cell culture and transfection
The human SDC DNA constructs were prepared as described above
and transfected into K562 cells with DMRIE-C (Invitrogen) to prepare
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the truncated forms of SDC1 and SDC4. Transfections were carried out
according to the recommendations of the manufacturer. After 24 h,
cells were incubated with selection medium, containing 0.4 mg/ml
G418 (Sigma). The selection medium was changed every second day.
After 2 weeks, G418-resistant colonies were analyzed for the protein
expression with ﬂow cytometry using speciﬁc antibodies against the
given SDC isoforms (anti-human SDC1 [Clone 359103], anti-human
SDC2 [Clone 305515], and anti-human SDC4 [all R&D Systems, Inc.]).
Thus colonies exhibiting similar extent of SDC1, SDC2 or SDC4
expression were chosen for further studies. The erythroleukemia cell
line K562 and its clones were grown as a suspension culture in RPMI
1640 medium (Gibco) supplemented with 10% fetal calf serum (FCS;
Gibco) at 37 °C in a humiﬁed 5% CO2 containing air environment.
2.3. Flow cytometry
Expression of SDC1, SDC2 and SDC4 in K562 transfectants was
measured with a FACScan (Becton Dickinson) using speciﬁc anti-
bodies (anti-human SDC1 [Clone 359103], anti-human SDC2 [Clone
305515], and anti-human SDC4) against the studied SDC isoform
according to the recommendations of the manufacturer (R&D
Systems, Inc.). In the case of GFP-tagged SDC1 and SDC4 mutants,
expression was also analyzed with ﬂow cytometry measuring the
ﬂuorescence intensities of the GFP tags. Thus clones with equal
amount of SDC expression were selected and used to quantify of the
internalization of the ﬂuorescent CPPs or ﬂuorescein-conjugated
transferrin (Invitrogen). Brieﬂy, 6×105 cells/ml in RPMI 1640
medium (without FCS) were incubated with the ﬂuorescently (FITC
or Alexa555) labeled CPPs (penetratin, R8 and TAT, respectively) or
transferrin at a concentration of 5 μM and 25 μg/ml, respectively, for
60 min at 37 °C. In the case of the FITC-labeled peptides and
ﬂuorescein-conjugated transferrin, after the 60 min of incubation
the cells werewashed twice in ice-cold PBS and resuspended in 0.5 ml
of physiological saline. Equal volumes of this suspension and a stock
solution of trypan blue (Merck KGaA; 500 μg/ml dissolved in ice-cold
0.1 M citrate buffer at pH 4.0) were allowed to mix for 1 min before
the ﬂow cytometric analyses. In this way, sample pH was lowered to
pH 4.0, thereby optimizing the quenching effect of trypan blue [45]. In
the case of the SDC1 and SDC4 deletion mutants treated with the
Alexa555-labeled CPPs, extracellular ﬂuorescence of surface attached
peptides was removed by trypsinization according to the method
described by Nakase et al. [13]. Cellular uptake was then measured by
ﬂow cytometry using a FACScan (Becton Dickinson). A minimum of
10,000 events per sample was analyzed. Viability of cells was
determined by using appropriate gating to exclude dead cells, debris,
and aggregates in a forward-scatter-against-side-scatter plot.
2.4. Confocal laser scanning microscopy
Internalization of the ﬂuorescently labeled (FITC or Alexa555) CPPs
into K562 cells and SDC transfectants was visualized by confocal laser
scanningmicroscopy. Cellswere grownonpoly-D-lysine-coated glass-
bottom 35-mm culture dishes (MatTek Corp.). After 24 h, the cells
were preincubated in RPMI 1640 medium (supplemented with 10%
FCS) at 37 °C for 30 min before incubation with the ﬂuorescently
labeled (FITC or Alexa555)CPPs (penetratin, R8 and TAT, respectively).
TheCPP solutionwas prepared at a concentration of 5 μMinRPMI 1640
medium (without FCS) by a dilution of a 1 mM stock solution of
peptide in phosphate-buffered saline (PBS). After 60 min at 37 °C, the
cellswere rinsed three timeswith ice-cold PBS and nucleiwere stained
with 2 μg/ml Hoechst 33258 (Sigma) for 10 min. Distribution of
ﬂuorescence was then analyzed on an Olympus FV1000 confocal laser
scanning microscope equipped with three lasers. A laser diode
(excitation, 405 nm) and a band-pass ﬁlter (420–480 nm) were used
to capture the signal recorded as blue; an argon laser (excitation,488 nm) and a band-pass ﬁlter (505–530 nm) were used to capture
the signal recorded as green; and ﬁnally, a helium/neon laser
(excitation, 543 nm) and a band-pass ﬁlter (550–625 nm) were used
to capture the signal recorded as red. Sections presented were taken
approximately at the mid-height level of the cells. Photomultiplier
gain and laser power were identical within each experiments. FV10-
ASW software was used for image acquisition by confocal microscopy.
2.5. Endocytosis inhibitor studies
To deplete intracellular ATP pools, cells were treated with sodium
azide (NaN3; Sigma) as described previously [46]. To study the effect
of proteoglycan sulfation, cells were incubated with 60 mM sodium
chlorate (NaClO3; Sigma) for 48 h prior to CPP treatment as described
by Fadel and Eley [47]. To reveal the involvement of PKCα, some cells
were preincubated with Gö 6976 (1 μM; Sigma) 30 min before FITC-
CPP treatment. Effect of macropinocytosis was investigated by
preincubating the cells with 5-(N-ethyl-N-isopropyl) amiloride
(Sigma) at a concentration of 500 μM as described previously
[34,48]. After incubation with these inhibitors, the cells were treated
with FITC-labeled CPPs (penetratin, R8 and TAT, respectively) and
processed for the ﬂow cytometric analyses as described above.
2.6. Statistical analysis
Results are expressed as means±S.E. Differences between
experimental groups were evaluated by using analysis of variance
(ANOVA). Values of pb0.05 were accepted as signiﬁcant.
3. Results
3.1. Contribution of the most common SDC isoforms to CPP uptake
Up-till-now no speciﬁc cellular receptor that facilitates CPP uptake
has been deﬁned. Therefore we investigated K562 cells transfected
with the most common isoforms (1, 2 and 4) of the SDC family and
tested them for internalization of the three most frequently utilized
CPPs: penetratin, R8 and TAT. First we analyzed SDC expression of
transfectantswithﬂow cytometry using speciﬁc antibodies against the
studied SDC isoforms. Thus transfectants with equal amount of SDC
expression were selected and along with wild-type K562 cells were
treated with the FITC-labeled CPPs (penetratin, R8 and TAT, respec-
tively) at a concentration of 5 μM for 60 min at 37 °C. After incubation
with the peptides, cellular uptake into live cells was analyzed with
confocalmicroscopy. As it iswell-established, the erythroleukemia cell
line K562 does not express SDCs and glypicans at the cell surface, but
expresses small amounts of betaglycan-transforming growth factor
beta receptor III (TGFßR-III) [49,50]. Accordingly, wild-type K562 cells
treated with the FITC-labeled CPPs gave relatively low level of
intracellular ﬂuorescence, while SDC transfectants showed more
pronounced ﬂuorescence intensities, especially those expressing
SDC4, demonstrating enhanced CPP entry due to SDC4 expression
(Fig. 2A). Note that signals detected from the CPP-treated cells were
coming from vesicle-like intracytoplasmic structures, a characteristic
feature of endocyosis.
Contribution of SDC isoforms to CPP uptake was also quantiﬁed
with quantitative ﬂow cytoﬂuorometric assays. To enable exact
assessment of CPP translocation, extracellular ﬂuorescence of surface
bound ﬂuorescent (FITC) peptides was quenched by adding trypan
blue (dissolved at a concentration of 0.25% in ice-cold 0.1 M citrate
buffer) 1 min before the analyses [45]. Consistent with previous
microscopic studies, intracellular ﬂuorescence signal of SDC transfec-
tants was higher compared to intensities detected in wild-type K562
cells. In these ﬂow cytometric studies SDC4 transfectants presented
the highest ﬂuorescence signals, indicating that SDC4 enhanced
internalization of the investigated cationic CPPs the most (Fig. 2B–D).
Fig. 2. CPP uptake into K562 cells and SDC transfectants. K562 cells and transfectants of human SDC1, SDC2 and SDC4 were incubated with the FITC-labeled CPPs (penetratin, R8 and
TAT, respectively) at a concentration of 5 μM for 60 min at 37 °C. After 60 min of incubation, cellular uptake was analyzed with confocal microscopy or ﬂow cytometry. (A) Confocal
microscopic visualization of CPP entry into SDC transfectants. Nuclei of cells were stained with Hoechst 33258 dye. Scale bar=10 μM. (B–D) Flow cytometric analyses of CPP uptake.
Detected ﬂuorescence intensities normalized to FITC-CPP-treated wild-type K562 cells as standards. The bars represent mean±S.D. of six independent experiments. Statistical
signiﬁcance between CPP-treated cells was assessed by analysis of variance (ANOVA). *pb0.05 vs wild-type K562 cells; **pb0.01 vs wild-type K562 cells.
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difference could be detected in ﬂuorescence of transfectants and
wild-type K562 cells, showing that SDC overexpression do not affect
clathrin-mediated endocytosis (results not shown).
Further confocal microscopic studies on transfectants expressing
green ﬂuorescent protein (GFP)-tagged SDC4 showed the intracellular
colocalization of SDC4 and cationic CPPs (Fig. 3), providing additional
evidence on the signiﬁcant involvement of SDC4 in CPP entry. These
colocalization studies demonstrated the common intracellular entryFig. 3. Intracellular colocalization of SDC4 and cationic CPPs. Transfectants expressing
GFP-tagged SDC4 with the Alexa-labeled CPPs (penetratin, R8 and TAT, respectively) at
a concentration of 5 μM for 60 min at 37 °C. After 60 min of incubation, nuclei of cells
were stained with Hoechst 33258 dye and cellular uptake was analyzed with confocal
microscopy. Scale bar=10 μM.of SDC4 and the CPPs, suggesting that cationic CPPs translocate to the
cells bound to the SDC4 rather than just penetrating alone.
3.2. Contribution of various parts of the SDC4 ectodomain to CPP uptake
After identifying SDC4 as the main facilitator of cellular entry of the
cationic CPPs, we examined the inﬂuence of various parts of the SDC4
extracellular domain on CPP uptake. First we generated three deletion
mutants missing different parts of SDC4 extracellular domain (Fig. 4A).
Plasmid CBD.pSi4 encoded a SDC4 core protein with a mutant
ectodomain containing only the cell-binding domain (CBD) and signal
sequence (Si), but no HS attachment (HSA) site and HS chains. Plasmid
pSi4 encoded a SDC4 deletion mutant with a truncated extracellular
domain made of only the signal sequence (Si), while plasmid HSA.pSi4
encoded a SDC4 mutant with and ectodomain comprising the signal
sequence (Si) andHSA sitewithHS chains. Since SDC1 and SDC4possess
HS chains that have almost identical structures, we also generated a
plasmid (HSA.pSi1) encoding a mutant SDC1 with an ectodomain
consisting of the signal sequence (Si) and the HSAwith HS chains. All of
the above mentioned plasmids were tagged with GFP and transfected
into K562 cells. Clones with equal extent of SDC expression were then
selected with ﬂow cytometry and treated with the Alexa Flour® 555
(Alexa555)-labeled cationic CPPs (penetratin, R8 and TAT, respectively)
at a concentration 5 μM for 60 min at 37 °C. Among the CPP-treated
cells, the highest ﬂuorescence was measured on wild-type SDC4
transfectants, demonstrating the importance of the full extracellular
domain of SDC4 in attaching and translocating cationic CPPs (Fig. 4B–D).
Compared to wild-type SDC4 transfectants, pSi4 mutants (expressing a
truncated ectodomain made of only a short signal sequence) displayed
the lowest level of cellular ﬂuorescence, reﬂecting the low level of CPP
cellular entry. CPP uptake into CBD.pSi4mutants (with a full CBD and Si
containing ectodomain) was also quite low relative to transfectants of
Fig. 4. Contribution of various parts of the SDC4 ectodomain to CPP uptake. (A) Schematic representation of SDC1 and SDC4 deletion mutants used in the study. (B–D) Results of ﬂow
cytometric measurements. Detected ﬂuorescence intensities are normalized to Alexa555-CPP-treated wild-type SDC4 transfectants as standards. The bars represent mean±S.D. of
six independent experiments. Statistical signiﬁcance between CPP-treated cells was assessed by analysis of variance (ANOVA). *pb0.05 vs wild-type SDC4 transfectants; **pb0.01 vs
wild-type SDC4 transfectants.
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in interaction with the cationic CPPs. HSA.pSi4 mutants (with SDC4
ectodomain containing Si and HSA site with HS chains) exhibited more
pronounced cellular ﬂuorescence that surmounted intensities detected
on SDC1 mutants with HS-only extracellular domain (HSA.pSi1),
indicating that apart from the almost identical HS chains, other
subdomains of the SDC4 core protein inﬂuence the internalization
process.
3.3. Effect of endocytosis inhibitors on CPP uptake
Our previous assays on SDC transfectants showed that SDCs,
especially SDC4 greatly enhanced uptake of the cationic CPPs.
Moreover, colocalization studies showed that SDC4 and the CPPs
enter the cells together. On the other hand, CPP internalization could
be still detected on K562 cells devoid of SDCs, suggesting that SDC4-
dependent uptake might be a supreme, but not the only mechanism
responsible for CPP translocation. In order to reveal the nature of
uptake mechanisms excluding SDC4 and other SDCs, we treated K562
cells and transfectants with various inhibitors of endocytosis and
tested their effects on CPP uptake.
Endocytic uptake of CPPs is still under a heavy dispute. Since early
studies claimed the ATP-independent, non-endocytic uptake of CPPs
[10], thus we studied cellular uptake into ATP-depleted cells. In our
assays, ATP depletion with sodium azide (NaN3) greatly diminished
CPP uptake in all of the involved cell-lines, indicating the insigniﬁ-
cance of ATP-independent, non-endocytic penetration of the cationic
CPPs (Fig. 5A–C).
It has been also widely suggested that HSPGs serve as an initial
receptor for the adherence and subsequent internalization of cationicCPPs. Interactions of PGs with cationic ligands are mediated by
sulfated regions of the HS chains. This raises the possibility that
variation in sulphation might have considerable biological ramiﬁca-
tions on CPP internalization. To examine the effect of sulfate
constituents on uptake of the studies cationic CPPs, we incubated
K562 cells and transfectants with sodium chlorate (NaClO3), an agent
known to promote undersulfation of PGs [51]. According to ﬂow
cytometric studies, chlorate treatment resulted in marked reduction
of CPP uptake in K562 cells and SDC transfectants (Fig. 5A–C). As ﬂow
cytometric studies without using the quenching effect of trypan blue
pointed out, sodium chlorate led to the decrease of overall (both intra-
and extra-) cellular ﬂuorescence, meaning that undersulfation
abrogates even the attachment of cationic CPPs to the membrane
surface (results not shown).
SDC4 can bind and activate PKCα via a tetrameric activation
complex formed by a SDC4 dimer and two molecules of phosphati-
dylinositol 4,5-bisphosphate (PIP2) [29–31,52,53]. Considering this
interplay between SDC4 and PKCα, we tested the effect of the
selective PKCα inhibitor Gö 6976 on CPP translocation. Gö 6976
greatly decreased cellular internalization of all investigated CPPs. The
extent of decrease however was quite different between the various
cell-lines as SDC1 transfectants showed the less diminished CPP
uptake and SDC4 transfectants the most (Fig. 5A–C).
Macropinocytosis has already been suggested as the major uptake
mechanism of arginine-rich CPPs [54]. Thus we examined the effects
of amiloride, an agent reported as a potent inhibitor of macropino-
cytosis [34,48], on the internalization of the cationic CPPs. In our
assays, amiloride has signiﬁcantly decreased cellular uptake of all
CPPs in all cell-lines (Fig. 5A–C), suggesting the macropinocytotic
uptake of cationic CPPs.
Fig. 5. Effects of various endocytosis inhibitors on CPP uptake. K562 cells and
transfectants of SDC1, SDC2 and SDC4 were incubated with the FITC-labeled CPPs
(penetratin, R8 and TAT, respectively) at a concentration of 5 μM for 60 min at 37 °C and
uptake was measured with ﬂow cytometry. Some cells were incubated with sodium
azide (NaN3), others with sodium chlorate (NaClO3) or Gö 6796 or amiloride prior to
CPP treatment at 37 °C. Detected ﬂuorescence intensities were normalized to CPP-
treated wild-type K562 cells as standards. The bars represent mean±S.D. of six
independent experiments.
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Cell-penetration by certain biological entities (i.e. viruses) are
facilitated by relatively short cationic subdomains, so called CPPs with
a length of about 30 amino acids [55–57]. Man made CPPs, even in
context with molecular conjugates, can be exploited to facilitate
translocation of otherwise membrane impermeable biomolecules
[1,2,5,58,59]. More than ﬁfteen years after the discovery of the ﬁrst
conceptualized CPPs, penetratin and TAT, cellular entry of CPPs still
addresses many questions [11]. One of the most important questions
waiting to be answered was the role of cell surface receptors in CPP
uptake [60–62]. Until now no cellular receptor that enhances the
uptake of CPPs has been identiﬁed. Although the role of polyanionic
membrane proteoglycans in CPP uptake has already been implied, the
speciﬁc proteoglycan responsible for the unique internalization of
CPPs has not been revealed. The HS chains of SDCs, a family oftransmembrane proteoglycans are depicted as the main attachment
site for many viruses, parasites and cationic gene delivery systems,
but so far this is the ﬁrst study providing direct evidence on SDC-
mediated CPP uptake.
Our assays on SDC transfectants demonstrated that SDCs did
facilitate uptake of the most frequently utilized representatives of
cationic CPPs (penetratin, R8 and TAT), while uptake of transferrin, a
well-established marker of clathrin-mediated endocytosis, was not
affected. The extent of CPP uptake however was quite different
between transfectants of the various SDC isoforms (1, 2 and 4).
Particularly SDC4 enhanced CPP cellular entry: almost tripling cellular
internalization of all of the studied CPPs. Colocalization studies
revealed that SDC4 and the CPPs translocate into the cytosol together,
suggesting that cationic CPPs are actually transported into the cell as
ligands bound to SDC4. Interaction of the CPPs with SDC4 depends
highly on HS chains and less on other parts of the SDC4 ectodomain
including the CBD that mediates cell–cell attachment. The observed
difference of cationic CPP uptake between SDC1 and SDC4 transfec-
tants is indeed very interesting. Zako et al. has already reported that
HS chains of SDC1 and SDC4 are structurally almost indistinguishable
[63]. Thus the difference in CPP uptake between SDC1 and SDC4
mutants with truncated ectodomains made of only HSA sites and HS
chains suggest that apart from the HS chains, the intracellular domain
of SDC4 also contribute to the superior ability of SDC4 to mediate CPP
internalization. The interplay between the intracellular domain of
SDC4 and PKCα and is already well documented [64–66]. Therefore,
diminished CPP uptake due to selective inhibition of PKCα further
justiﬁed the role of SDC4 in CPP internalization. And although to a
various extent, but Gö 6976 exerted general inhibition on CPP uptake
into all of the investigated cell types, not just SDC4 transfectants,
indicating the universal importance of PKCα in the internalization
mechanism. Thus PKCα activation, independent of SDC4, is necessary
for CPP uptake. Since uptake of CPPs at a lower level could be still
detected onwild-type K562 cells (expressing small amounts of TGFßR
III), it also became evident that internalization of the CPP was not
conﬁned to SDC4 or the other SDCs. As studies on sodium chlorate-
treated cells pointed out, uptake mechanisms excluding SDCs still
heavily rely on other PGs. According to our studies with ATP-depleted
or cells, cationic CPP uptake, either mediated by SDCs or other PGs, is
an ATP-dependent, endocytotic process. Macropinocytosis also plays
part in the internalization of cationic CPPs.
In summary our data provides evidence that SDC4 binds and
mediates transport of model cationic CPPs (penetratin, R8 and TAT)
through the plasma membrane into the cells. Our study demonstrates
that cationic CPPs, unlike stated in previous studies, act as ligands,
preferentially of SDC4, rather than cell-penetrating molecules during
the internalization process. It also became evident, that apart from
SDC4, to a smaller extent other SDCs and PGs can facilitate CPP
membrane translocation that heavily relies on PKCα activity. For
small Trojan CPPs like penetratin, R8 and TAT, exploiting various
endocytic routes simultaneously is the key to ensure certain entry into
the cells. In this sense, SDC4 is a supreme, but not the sole mediator of
CPP uptake. The fact that cationic CPPs can utilize multiple cellular
receptors (whether it is SDC4 or other PGs) and internalization
pathways is actually favorable. And although the identiﬁcation of
SDC4 as a main plasma membrane carrier of penetratin, R8 and TAT
presents a great advance in the understanding of the unique
translocational properties of cationic CPPs, still there is a long road
ahead till we could fully reveal every single route of CPP entry into the
cells.
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